NASDAQ · KALA
KALA BIO, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for KALA: Nov 18, 2026
KALA BIO, Inc. Common Stock is estimated to report earnings on 11/18/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-53.5.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Fintel- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Sep 30, 5:57 AM EDTKALA Bio Signs LOI To Acquire Nationwide Telehealth Platform; Shares Rise(RTTNews) – KALA Bio, Inc. (KALA) moves to expand its healthcare business through a proposed acquisition valued at approximately $15 million.
- RTTNews · Sep 25, 10:53 AM EDTWeekly Buzz: MESO, LLY, ANIP Win FDA Nod; KALA, HCTI Sign LOI; IMVT Halts Lupus Study(RTTNews) – Biotech and pharma companies delivered a busy slate of updates, spanning regulatory approvals, multibillion-dollar drug discovery partnerships and pivotal clinical-trial readouts across oncology, metabolic diseases, immunology and rare diseases.
- RTTNews · Sep 24, 8:29 AM EDTKala Bio And Virotek Sign LOI To Expand Genetic Testing Distribution(RTTNews) – Kala Bio, Inc. (KALA) announced that it and Virotek Inc. have signed a non-binding letter of intent with a U.S. DNA testing platform under which the platform would resell selected genomic testing products from Virotek.
- RTTNews · Sep 1, 11:02 AM EDTKala Bio Signs LOI With Virotek For Exclusive U.S. Distribution; Stock Down(RTTNews) – Kala Bio, Inc. (KALA) announced it has entered into a letter of intent (LOI) with Virotek Inc., a CLIA-registered precision health and clinical genomics company, to establish an exclusive U.S. distribution partnership for Virotek's ophthalmology genetic testing and sc
- RTTNews · Mar 11, 7:17 AM EDTKala Bio Surges 75% On AI Healthcare Breakthrough(RTTNews) – Shares of Kala Bio, Inc. (KALA) jumped more than 75% in pre-market trading after the company announced it will deploy its first commercial AI agent within 14 days, marking a major shift from a single-asset biotech into a dual-engine growth story.
- RTTNews · Jan 6, 6:30 AM ESTKALA BIO Clears Oxford Debt – A Fresh Start Ahead?(RTTNews) – KALA BIO, Inc. (KALA) has eliminated a major financial overhang by completing a loan settlement with Oxford Finance, resolving approximately $10.6 million in debt obligations and strengthening the company's balance sheet.
- Zacks · Oct 8, 11:18 AM EDTKALA Stock Crashes 88% in a Month Following Eye Disorder Study FailureKALA BIO stock plunges 88% after its KPI-012 eye disorder study fails to meet goals, forcing the company to scrap its pipeline and explore strategic options.
- Fintel · Sep 30, 2:08 AM EDTKALA BIO (KALA) Price Target Increased by 23.00% to 31.36The average one-year price target for KALA BIO (NasdaqCM:KALA) has been revised to $31.36 / share. This is an increase of 23.00% from the prior estimate of $25.50 dated September 10, 2025. The price target is an average of many targets provided by analysts. Th
- RTTNews · Sep 29, 9:26 AM EDTKALA Bio's KPI-012 Fails Phase 2b CHASE Study; Shares Plunge Over 90% In Pre-Market(RTTNews) – KALA Bio, Inc. (KALA) on Monday announced that its CHASE Phase 2b study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED) did not meet the primary endpoint of complete healing of PCED at Week 8. Following the news, the company's shares were d
- RTTNews · Sep 5, 5:28 AM EDTIs KALA BIO On The Verge Of A Pivotal Moment With KPI-012?(RTTNews) – KALA BIO Inc. (KALA) is in focus, as anticipation builds around its upcoming clinical trial data for KPI-012, a novel stem cell-derived therapy targeting persistent corneal epithelial defect or PCED, a rare and debilitating eye condition with no FDA-approved treatment
- RTTNews · Sep 2, 9:45 AM EDTKALA BIO Promotes President And COO Todd Bazemore To President And CEO(RTTNews) – Biopharmaceutical company KALA BIO, Inc. (KALA) announced Tuesday that Todd Bazemore has been named President and Chief Executive Officer (CEO) and appointed to the Board of Directors.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for KALA BIO, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.